Skip to main content

Ventas Value Stock - Dividend - Research Selection

Ventas

ISIN: US92276F1003 , WKN: 878380

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of more than 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. References to ?Ventas? or the ?Company? mean Ventas, Inc. and its consolidated subsidiaries unless otherwise expressly noted. More information about Ventas and Lillibridge can be found at www.ventasreit.com and www.lillibridge.com.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


The Truce Is Loose

2026-07-12
Stocks rose into earnings season despite higher rates and renewed Iran-Hormuz risks. Click for an updated market outlook.

Ventas: Ahead Of Q2 Results, Lots To Like About This Senior-Care REIT

2026-07-12
Ventas REIT analysis: senior housing tailwinds, strong balance sheet and dividend coverage, but pricey 23x P/E limits upside. Click for more on VTR stock.

Janus Living: The Pure Play On Senior Housing Growth

2026-07-07
Janus Living stands as the only pure-play senior housing REIT, offering direct SHOP exposure and unique sector positioning. Read the full analysis on JAN here.

Barclays Initiates Coverage of Ventas (VTR) with Equal-Weight Recommendation

2026-07-07

Here's What to Expect From Ventas’ Next Earnings Report

2026-07-07
Ventas will release its second-quarter earnings later this month, and analysts anticipate a low double-digit FFO growth.

Here Are Tuesday’s Best Wall Street Analyst Research Calls: Adobe, American Airlines, Broadcom, First Solar, Meta Platforms, Shopify, Space-X, Ventas, Waste Managment, and More

2026-07-07
Pre-Market Stock Futures: Futures are trading mixed, with the Nasdaq getting hammered after a gangbuster start to the first full trading week of the third quarter. All of the major indices finished the day higher, with chip stocks once again leading the way. When the dust settled at the close, the Nasdaq finished the day ... Here Are Tuesday’s Best Wall Street Analyst Research Calls: Adobe, American Airlines, Broadcom, First Solar, Meta Platforms, Shopify, Space-X, Ventas, Waste Managment, and M

Barclays Initiates Coverage On Ventas with Equal-Weight Rating, Announces Price Target of $99

2026-07-07
Barclays analyst Richard Hightower initiates coverage on Ventas (NYSE:VTR) with a Equal-Weight rating and announces Price Target of $99.

Equity REITs: Takeaways From REITWeek 2026

2026-07-05
REITs may deliver 6–7% earnings growth as shopping centers, healthcare, data centers and select offices lead.

Sparks From The Warsh Fed

2026-07-05
U.S. equity markets advanced as softer employment data eased fears of a more aggressive Fed path. Read more on the real estate market here.

Evercore ISI Group Maintains Outperform on Ventas, Raises Price Target to $96

2026-07-01
Evercore ISI Group analyst Steve Sakwa maintains Ventas (NYSE:VTR) with a Outperform and raises the price target from $95 to $96.